Related Experiment Videos
Thromboxane A2 and prostacyclin do not modulate pulmonary hemodynamics during exercise in sheep
Journal of Applied Physiology (Bethesda, Md. : 1985)
|November 1, 1986
Summary
Neither thromboxane A2 nor prostacyclin significantly impact pulmonary hemodynamics in healthy lungs during maximal exercise or hypoxia. These eicosanoids do not modulate pulmonary vascular resistance under various exercise conditions.
Area of Science:
- Cardiovascular Physiology
- Pulmonary Circulation
- Exercise Physiology
Background:
- Pulmonary hemodynamics are crucial for oxygen delivery during exercise.
- Thromboxane A2 and prostacyclin are potent vasoactive mediators.
- Their specific roles in the healthy lung during maximal exercise remain unclear.
Purpose of the Study:
- To investigate the role of thromboxane A2 and prostacyclin in modulating pulmonary hemodynamics.
- To assess these roles during maximal cardiopulmonary stress in healthy lungs.
Main Methods:
- Studied 11 yearling sheep during progressive maximal treadmill exercise.
- Administered cyclooxygenase or thromboxane synthesis inhibitors (meclofenamate, ibuprofen, UK38485).
- Measured thromboxane B2 and 6-ketoprostaglandin F1 alpha in plasma and lung lymph during exercise, hypoxia, and prolonged exercise.
Main Results:
- Progressive exercise reduced pulmonary vascular resistance, unaffected by drug treatment.
- Plasma thromboxane B2 increased minimally during maximal exercise; 6-ketoprostaglandin F1 alpha did not change.
- Neither metabolite altered pulmonary vascular resistance during hypoxia or prolonged exercise.
Conclusions:
- Thromboxane A2 and prostacyclin do not modulate pulmonary hemodynamics in the normal lung.
- This lack of modulation holds true for maximal exercise, prolonged moderate exercise, and hypoxia-induced vasodilation during exercise.